The Central Drugs Standard Control Organisation (CDSCO) has issued a public notice requesting that Samples of Cough Syrup be submitted to labs other than CDTL Mumbai and IPC Ghaziabad Labs. This notice was issued on 3rd July, 2023.
It may be recalled that CDSCO had by a notification dated 13th June, 2023 decided to update the number of batches of cough syrups it receives at different labs on its website. This measure was intended to foster work distribution among the labs and release of test reports in a timely manner.
Pursuant to this, CDSCO had observed that based on data for 21st June, 2023, CDTL Mumbai Lab had 93 samples of cough syrup under testing. It was also observed that some other laboratories did not have any samples under testing. Hence CDSCO had issued a notice requesting that samples of cough syrup be submitted to labs other than CDTL Mumbai Lab.
Now, based on data from 3rd July, 2023, CDSCO has observed that both CDTL Mumbai and IPC Ghaziabad Labs have more than 100 samples of cough syrup under testing. While at the same time it has observed that some of the other laboratories do not have any samples under testing.
Hence, to rectify this, CDSCO has instructed all manufacturers and exporters to refrain from submitting any samples to CDTL Mumbai and IPC Ghaziabad Labs until it completes analysis and release of pending reports.
Manufacturers and exporters are also requested to verify the pendency of sample testing on the CDSCO website on a daily basis and to submit their samples to laboratories that have no/ less samples.
